187 related articles for article (PubMed ID: 22739661)
1. Association of stress management skills and perceived stress with physical and emotional well-being among advanced prostrate cancer survivors following androgen deprivation treatment.
Penedo FJ; Benedict C; Zhou ES; Rasheed M; Traeger L; Kava BR; Soloway M; Czaja S; Antoni MH
J Clin Psychol Med Settings; 2013 Mar; 20(1):25-32. PubMed ID: 22739661
[TBL] [Abstract][Full Text] [Related]
2. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
[TBL] [Abstract][Full Text] [Related]
3. Coping and health-related quality of life in men with prostate cancer randomly assigned to hormonal medication or close monitoring.
Green HJ; Pakenham KI; Headley BC; Gardiner RA
Psychooncology; 2002; 11(5):401-14. PubMed ID: 12228873
[TBL] [Abstract][Full Text] [Related]
4. Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy.
Sevilla C; Maliski SL; Kwan L; Connor SE; Litwin MS
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):237-43. PubMed ID: 22289781
[TBL] [Abstract][Full Text] [Related]
5. Positive and negative mood in men with advanced prostate cancer undergoing androgen deprivation therapy: considering the role of social support and stress.
Benedict C; Dahn JR; Antoni MH; Traeger L; Kava B; Bustillo N; Zhou ES; Penedo FJ
Psychooncology; 2015 Aug; 24(8):932-9. PubMed ID: 25251737
[TBL] [Abstract][Full Text] [Related]
6. Predictors of health-related quality of life in Korean prostate cancer patients receiving androgen deprivation therapy.
Kim SH; Seong DH; Yoon SM; Choi YD; Choi E; Song H
Eur J Oncol Nurs; 2017 Oct; 30():84-90. PubMed ID: 29031319
[TBL] [Abstract][Full Text] [Related]
7. Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy.
Benedict C; Traeger L; Dahn JR; Antoni M; Zhou ES; Bustillo N; Penedo FJ
J Sex Med; 2014 Oct; 11(10):2571-80. PubMed ID: 25059094
[TBL] [Abstract][Full Text] [Related]
8. Predictors of physical activity and quality of life in New Zealand prostate cancer survivors undergoing androgen-deprivation therapy.
Keogh JW; Shepherd D; Krägeloh CU; Ryan C; Masters J; Shepherd G; MacLeod R
N Z Med J; 2010 Nov; 123(1325):20-9. PubMed ID: 21317957
[TBL] [Abstract][Full Text] [Related]
9. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.
Lubeck DP; Grossfeld GD; Carroll PR
Urology; 2001 Aug; 58(2 Suppl 1):94-100. PubMed ID: 11502459
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
Lee CE; Leslie WD; Lau YK
BMC Cancer; 2012 Mar; 12():103. PubMed ID: 22436542
[TBL] [Abstract][Full Text] [Related]
11. Perceptions of physically active men with prostate cancer on the role of physical activity in maintaining their quality of life: possible influence of androgen deprivation therapy.
Keogh JW; Patel A; MacLeod RD; Masters J
Psychooncology; 2013 Dec; 22(12):2869-75. PubMed ID: 23904113
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in prostate cancer patients taking androgen deprivation therapy.
Dacal K; Sereika SM; Greenspan SL
J Am Geriatr Soc; 2006 Jan; 54(1):85-90. PubMed ID: 16420202
[TBL] [Abstract][Full Text] [Related]
13. Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?
Karunasinghe N; Zhu Y; Han DY; Lange K; Zhu S; Wang A; Ellett S; Masters J; Goudie M; Keogh J; Benjamin B; Holmes M; Ferguson LR
BMC Urol; 2016 Aug; 16(1):48. PubMed ID: 27485119
[TBL] [Abstract][Full Text] [Related]
14. Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy.
Nilsen TS; Raastad T; Skovlund E; Courneya KS; Langberg CW; Lilleby W; Fosså SD; Thorsen L
Acta Oncol; 2015 Nov; 54(10):1805-13. PubMed ID: 25927504
[TBL] [Abstract][Full Text] [Related]
15. Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy.
Wilding S; Downing A; Wright P; Selby P; Watson E; Wagland R; Donnelly DW; Hounsome L; Butcher H; Mason M; Henry A; Gavin A; Glaser AW
Qual Life Res; 2019 Oct; 28(10):2741-2751. PubMed ID: 31115843
[TBL] [Abstract][Full Text] [Related]
16. Perceived stress mediates the effects of social support on health-related quality of life among men treated for localized prostate cancer.
Zhou ES; Penedo FJ; Lewis JE; Rasheed M; Traeger L; Lechner S; Soloway M; Kava BR; Antoni MH
J Psychosom Res; 2010 Dec; 69(6):587-90. PubMed ID: 21109047
[TBL] [Abstract][Full Text] [Related]
17. A Qualitative Study Exploring the Perceptions of Sedentary Behavior in Prostate Cancer Survivors Receiving Androgen-Deprivation Therapy.
Trinh L; Arbour-Nicitopoulos KP; Sabiston CM; Alibhai SM; Jones JM; Berry SR; Loblaw A; Faulkner GE
Oncol Nurs Forum; 2015 Jul; 42(4):398-406. PubMed ID: 26148319
[TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation therapy: evidence-based management of side effects.
Ahmadi H; Daneshmand S
BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
[TBL] [Abstract][Full Text] [Related]
19. The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.
Holtfrerich SKC; Knipper S; Purwins J; Castens J; Beyer B; Schlomm T; Diekhof EK
Psychooncology; 2020 Aug; 29(8):1338-1346. PubMed ID: 32539186
[TBL] [Abstract][Full Text] [Related]
20. Androgen deprivation therapy's impact on the mood of prostate cancer patients as perceived by patients and the partners of patients.
Van Dam D; Wassersug RJ; Hamilton LD
Psychooncology; 2016 Jul; 25(7):848-56. PubMed ID: 26332203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
